The price per dose of the Russian coronavirus vaccine Sputnik V will be much lower than that of the vaccines of US drug giants Pfizer and Moderna, said the Russian vaccine’s official Twitter account on Sunday.
“Translating pharma lingo: the announced price of Pfizer of USD 19.50 and Moderna of USD 25-USD 37 per dose actually means their price of USD 39 and USD 50-USD 74 per person. Two doses are required per person for the Pfizer, Sputnik V and Moderna vaccines. The price of Sputnik V will be much lower,” the official account said.
Russia became the first country to register the world’s first COVID-19 vaccine on August 11. Sputnik V was developed by the Gamaleya National Research Centre for Epidemiology and Microbiology of the Russian Healthcare Ministry.
On November 11, Russia had said that its vaccine Sputnik V is 92 per cent effective at protecting people from COVID-19 according to the first interim analysis.
On November 17, Moderna, in its official statement, had announced that the independent, U.S. NIH-appointed Data Safety Monitoring Board (DSMB) for the Phase 3 study of mRNA-1273 has informed Moderna that the trial has met the statistical criteria pre-specified in the study protocol for efficacy, with a vaccine efficacy of 94.5%.
- राष्ट्रीय शिक्षा नीति-2020 के संबंध में राष्ट्रपति एवं प्रधानमंत्री के साथ राज्यपालों का सम्मेलन सम्पन्न - November 27, 2020
- New research suggests immunity to COVID is better than we first thought - November 27, 2020
- मध्यप्रदेश कराधान अधिनियमों की पुरानी बकाया राशि का समाधान अध्यादेश 2020 - November 27, 2020
- What can you expect if you get a call from a COVID contact tracer? - November 27, 2020
- ई-नगरपालिका पोर्टल की समीक्षा के लिये समिति गठित - November 27, 2020
- Sweden expects to reach virus peak in mid-December - November 27, 2020
- प्रदेश में सुदृढ़ अधोसंरचना तैयार करना मूल लक्ष्य - November 27, 2020
- Job changes increasingly common among U.S. radiologists - November 27, 2020
- यूरोपीय छाया से मुक्त करती है नई शिक्षा नीति - November 27, 2020
- Big data powers design of ‘smart’ cell therapies for cancer - November 27, 2020